Full name
ARISTO PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AXXON SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL.PUŁAWSKA 314, 02-819 WARSZAWA
TAX ID9512169876
Rate company:
AXXON SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9512169876
Share capital1,000,000.00 zł
address
UL.PUŁAWSKA 314, 02-819 WARSZAWA
Categories
Main category
Register Data
NIP
9512169876
REGON
140380965
KRS
0000245146
Legal form
limited liability company
ALEO.com Registration Date
2013-11-05
Register Address
UL. BALETOWA 30, 02-867 WARSZAWA
Date of registration in KRS
2005-11-16
Date of commencement of economic activity
2005-11-16
Act signature
WA.XIII NS-REJ.KRS/18049/25/485
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
20.52.Z - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.19.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
52.10.B - Warehousing and storage of other goods
Payer VAT status
Active
Vat list bank account(s)
PL22 1050 1012 1000 0090 3137 9887 
PL42 1160 2202 0000 0002 7855 5530 PL64 1050 1012 1000 0090 3137 9713 PL44 1050 1012 1000 0090 3137 9879 PL86 1050 1012 1000 0090 3137 9705 PL91 1050 1012 1000 0023 2387 2586 PL65 1050 1012 1000 0023 2793 9100 Show more bank accounts from VAT list (4)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 5,7 | 9,2 | 6,3 | -31,4 |
EBITDA | 7,8 | 11,4 | 8,3 | -27 |
Short time liabilities | 6,4 | 12 | 15,7 | 31,2 |
Equity capital | 15,1 | 20,2 | 18 | -10,8 |
Operating profit (EBIT) | 6 | 9,7 | 6,7 | -31 |
Assets | 26 | 35,3 | 38 | 7,8 |
Net profit (loss) | 4,6 | 7,3 | 5,2 | -29,7 |
Cash | 0,5 | 2,9 | 1,1 | -60,8 |
Net income from sale | 43,2 | 55,5 | 67,4 | 21,3 |
Liabilities and provisions for liabilities | 11 | 15,1 | 20 | 32,7 |
Working assets | 15,2 | 25,7 | 27,9 | 8,5 |
Depreciation | 1,7 | 1,6 | 1,6 | -3,3 |
% | % | % | p.p. | |
Profitability of capital | 30,6 | 36,4 | 28,7 | -7,7 |
Equity capital to total assets | 57,9 | 57,2 | 47,3 | -9,9 |
Gross profit margin | 13,1 | 16,6 | 9,4 | -7,2 |
EBITDA Margin | 18 | 20,4 | 12,3 | -8,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 54 | 79 | 85 | 6 |
Current financial liquidity indicator | 2.237245798110962 | -0,7 | ||
Net dept to EBITDA | 0.5748203992843628 | 0.5235662460327148 | 0.9318795204162598 | 0,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
VITAMIN CLINIC WROCŁAW
Wrocław
MEDDENT PEREK,LEWICKI
Kraków
Neuca S.A.
Toruń
CYTOGEN-POLSKA
ŁÓDŹ
Grand - Med Janina Pławska
Racław
PRZEDSIĘBIORSTWO WIELOBRANŻOWE INTERGOS
Bielsko-Biała
Sis-Med sp. z o.o.
Łódź
EUR-MED POLSKA
Katowice
"FARMEDICA" sp. z o.o.
Warszawa